| EMOLX | FNFWX | EMOLX / FNFWX | |
| Total Expense Ratio | 0.87 | 0.69 | 126% |
| Annual Report Gross Expense Ratio | 5.30 | 0.69 | 768% |
| Fund Existence | 5 years | 6 years | - |
| Gain YTD | 27.745 | 16.477 | 168% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 19.2M | 90B | 0% |
| Annual Yield % from dividends | 0.95 | 1.15 | 82% |
| Returns for 1 year | 35.76 | 17.30 | 207% |
| Returns for 3 years | 102.37 | 54.15 | 189% |
| Returns for 5 years | N/A | 19.42 | - |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ICTTX | 18.15 | 0.50 | +2.83% |
| ICON Health and Information Tech Inv | |||
| TWAIX | 14.71 | 0.12 | +0.82% |
| Thrivent International Equity S | |||
| MGIAX | 48.80 | N/A | N/A |
| MFS International Intrinsic Equity A | |||
| FHCIX | 73.98 | N/A | N/A |
| Fidelity Advisor Health Care I | |||
| MNHCX | 26.41 | N/A | N/A |
| Manning & Napier Pro-Blend Max Term L | |||